Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Bristol-Myers Squibb will pay $350 million to settle Hawaii's lawsuit over Plavix marketing practices, ending claims without ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

HPR's Ashley Mizuo reports on the settlement between two pharmaceutical companies, Sanofi and Bristol Myers Squibb in the ...

Bristol-Myers Squibb (BMY) and Sanofi (SNY) resolve Plavix marketing litigation with Hawaii in $700M settlement. Read more ...

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

Hawaiʻi will receive $700 million under a settlement with two major pharmaceutical companies that failed to properly label a ...

Pharmaceutical companies Bristol Myers Squibb and Sanofi have agreed to pay Hawaii USD 700 million to settle a lawsuit ...

Hawaii had alleged the companies violated state consumer protection laws by marketing Plavix without disclosing that the drug could have a diminished or no effect for some people, particularly of ...

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's ...